Cargando…

Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries

Substandard and falsified medicines are often reported jointly, making it difficult to recognize variations in medicine quality. This study characterized medicine quality based on active pharmaceutical ingredient (API) amounts reported among substandard and falsified essential medicines in low- and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozawa, Sachiko, Chen, Hui-Han, Lee, Yi-Fang (Ashley), Higgins, Colleen R., Yemeke, Tatenda T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209904/ https://www.ncbi.nlm.nih.gov/pubmed/35895431 http://dx.doi.org/10.4269/ajtmh.21-1123

Ejemplares similares

Educational and economic returns to cognitive ability in low- and middle-income countries: A systematic review
por: Ozawa, Sachiko, et al.
Publicado: (2022)

Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
por: Ozawa, Sachiko, et al.
Publicado: (2018)

Importance of medicine quality in achieving universal health coverage
por: Ozawa, Sachiko, et al.
Publicado: (2020)

Economic and cost-effectiveness aspects of vaccines in combating antibiotic resistance
por: Yemeke, Tatenda, et al.
Publicado: (2023)

Access to medicines through health systems in low- and middle-income countries
por: Ozawa, Sachiko, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on the quality of medical products in Zimbabwe: a qualitative study based on key informant interviews with health system stakeholders
por: Yemeke, Tatenda T, et al.
Publicado: (2023)

Funding gap for immunization across 94 low- and middle-income countries
por: Ozawa, Sachiko, et al.
Publicado: (2016)

Impact of the COVID-19 Pandemic on Medical Product Procurement, Prices, and Supply Chain in Zimbabwe: Lessons for Supply Chain Resiliency
por: Yemeke, Tatenda T., et al.
Publicado: (2023)

Out-of-Pocket Household Expenditures on Medical Injections in Cambodia
por: Ozawa, Sachiko, et al.
Publicado: (2018)

Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
por: Minaei, Hossein, et al.
Publicado: (2019)

Variations in global prices of chemotherapy for childhood cancer: a descriptive analysis
por: Habashy, Catherine, et al.
Publicado: (2023)

Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
por: Nebot Giralt, Ariadna, et al.
Publicado: (2020)

Health versus other sectors: Multisectoral resource allocation preferences in Mukono district, Uganda
por: Yemeke, Tatenda T., et al.
Publicado: (2020)

Improving mental health among people living with HIV: a review of intervention trials in low- and middle-income countries
por: Sikkema, K. J., et al.
Publicado: (2015)

Pharmaceutical quality assurance of local private distributors: a secondary analysis in 13 low-income and middle-income countries
por: Van Assche, Kerlijn, et al.
Publicado: (2018)

Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study
por: Hajjar, Rima, et al.
Publicado: (2017)

Mapping disparities in education across low- and middle-income countries
Publicado: (2019)

Successful ingredients of effective Collaborative Care programs in low- and middle-income countries: A rapid review
por: Whitfield, Jessica, et al.
Publicado: (2023)

The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries
por: Morgan, Steven G., et al.
Publicado: (2017)

Comparisons of Vaccine Hesitancy across Five Low- and Middle-Income Countries
por: Wagner, Abram L., et al.
Publicado: (2019)

Mapping child growth failure across low- and middle-income countries
Publicado: (2020)

Quality assurance of medicines supplied to low-income and middle-income countries: poor products in shiny boxes?
por: Nebot Giralt, A, et al.
Publicado: (2017)

Threats posed by stockpiles of expired pharmaceuticals in low- and middle-income countries: a Ugandan perspective
por: Kamba, Pakoyo Fadhiru, et al.
Publicado: (2017)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Essential medicines for breast cancer in low and middle income countries
por: Bazargani, Y. T., et al.
Publicado: (2015)

Strategies for Genomic Medicine Education in Low- and Middle-Income Countries
por: Sirisena, Nirmala D., et al.
Publicado: (2019)

Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020)

Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?
por: Griffiths, Ulla Kou, et al.
Publicado: (2016)

Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries
por: Perrin, Christophe, et al.
Publicado: (2020)

Socioeconomic inequalities in lifestyle risk factors across low- and middle-income countries
por: Dieteren, Charlotte, et al.
Publicado: (2021)

Chemical Engineering in the Pharmaceutical Industry, Active Pharmaceutical Ingredients
por: Ende, David
Publicado: (2019)

Effect of Patent Expiry on the Performance of Innovator Multinational Pharmaceutical Companies in a Low Middle Income Country
por: Khalil, Farrukh, et al.
Publicado: (2022)

Multiomics Characterization of Preterm Birth in Low- and Middle-Income Countries
por: Jehan, Fyezah, et al.
Publicado: (2020)

Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
por: Ravinetto, Raffaella, et al.
Publicado: (2016)

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
por: Stolbrink, M., et al.
Publicado: (2022)

The quality of malaria care in 25 low-income and middle-income countries
por: Macarayan, Erlyn, et al.
Publicado: (2020)

Access to medicines for acute illness in middle income countries in Central America
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2013)

Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches
por: Ozawa, Sachiko, et al.
Publicado: (2022)

Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market
por: Dat, Vu Quoc, et al.
Publicado: (2020)

Whistleblowing as an anti-corruption strategy in health and pharmaceutical organizations in low- and middle-income countries: a scoping review
por: Vian, Taryn, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_blpd0ccc3ofmfqfo4mt1h53l1k